Memorial Sloan-Kettering

After a promising feasibility study showing the potential of its natural language processing models, MSK has ambitions to use them in patient care.

Researchers aim to validate the AI tool SCORPIO in prospective studies and eventually seek FDA clearance to sell it as a commercial tool in the US.

A new study found that fewer African and Asian patients had clinically actionable alterations for lung, breast, and colorectal cancer.